These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus. Al-Adra DP, Gill RS, Imes S, O'Gorman D, Kin T, Axford SJ, Shi X, Senior PA, Shapiro AM. Transplantation; 2014 Nov 15; 98(9):1007-12. PubMed ID: 24911037 [Abstract] [Full Text] [Related]
53. Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan. Anazawa T, Saito T, Goto M, Kenmochi T, Uemoto S, Itoh T, Yasunami Y, Kenjo A, Kimura T, Ise K, Tsuchiya T, Gotoh M. Transplant Proc; 2014 Nov 15; 46(6):1980-4. PubMed ID: 25131088 [Abstract] [Full Text] [Related]
57. Over ten-year insulin independence following single allogeneic islet transplant without T-cell depleting antibody induction. Williams J, Jacus N, Kavalackal K, Danielson KK, Monson RS, Wang Y, Oberholzer J. Islets; 2018 Nov 15; 10(4):168-174. PubMed ID: 30024826 [Abstract] [Full Text] [Related]
58. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Turgeon NA, Avila JG, Cano JA, Hutchinson JJ, Badell IR, Page AJ, Adams AB, Sears MH, Bowen PH, Kirk AD, Pearson TC, Larsen CP. Am J Transplant; 2010 Sep 15; 10(9):2082-91. PubMed ID: 20883542 [Abstract] [Full Text] [Related]